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Edited by Felix WielandAbstract RNA silencing or RNA interference (RNAi) refers to
the small RNA-guided gene silencing mechanism conserved in a
wide range of eukaryotic organisms from plants to mammals. As
part of this special issue on the biology, mechanisms and applica-
tions of RNAi, here we review the recent advances on deﬁning a
role of RNAi in the responses of invertebrate and vertebrate ani-
mals to virus infection. Approximately 40 miRNAs and 10 RNAi
suppressors encoded by diverse mammalian viruses have been
identiﬁed. Assays used for the identiﬁcation of viral suppressors
and possible biological functions of both viral miRNAs and sup-
pressors are discussed. We propose that herpesviral miRNAs
may act as speciﬁcity factors to initiate heterochromatin assem-
bly of the latent viral DNA genome in the nucleus.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Homology-dependent gene silencing was discovered in
transgenic plants in the form of co-suppression between intro-
duced transgenes or between a transgene and its homologous
endogenous gene [1–4]. Similar gene silencing phenomena have
subsequently been described in a wide range of eukaryotic
organisms such as fungi [5], worms [6], ﬂies [7], and mammals
[8]. Both RNA silencing and RNA interference (RNAi) have
been used as generic terms to describe these related gene silenc-
ing mechanisms guided by small RNAs such as small interfer-
ing RNAs (siRNA) and microRNAs (miRNA).
A core feature of RNA silencing detected in all organisms is
the production of 21- to 26-nt small RNAs by the endoribo-
nuclease Dicer [9]. In Drosophila melanogaster, dicing of the
imperfectly base-paired precursor miRNAs (pre-miRNAs)
and the perfectly base-paired double-stranded RNA (dsRNA)
are carried out by two distinct Dicers, Dicer-1 and Dicer-2,
respectively. In contrast, both pre-miRNAs and dsRNA are
processed by the single Dicer in mammals and worms. The
resulting miRNAs and siRNAs are asymmetric [10] when they
are assembled into eﬀector complexes such as the RNA-in-
duced silencing complex (RISC). All eﬀector complexes de-*Corresponding author.
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doi:10.1016/j.febslet.2005.08.034scribed to date contain a member of the Argonaute (Ago)
protein family, containing the PAZ and PIWI domains [11].
siRNA and miRNA control the speciﬁcity of RNA silencing
by recruiting the eﬀector complex to a cognate single-stranded
RNA target, leading to either slicing, translational arrest, or
nascent RNA synthesis [9]. RNA synthesis by RNA-dependent
RNA polymerases (RdRP) ampliﬁes RNAi as it provides a
new source of dsRNA for the production of secondary siRNA
and may also be essential for the spread of RNAi to distal tis-
sues in some organisms [12]. Unlike Dicer and Ago, RdRP is
found only in fungi, plants and worms and the multiple-turn-
over RISC may mediate RNAi in the absence of a cellular
RdRP in D. melanogaster and mammalian cells [9].
Pioneering work by plant virologists has established that
plants respond to virus infection by inducing RNAi, leading
to speciﬁc recognition and destruction of the invading virus
RNAs and homologous host RNAs [13,14]. Plants infected
with either RNA or DNA viruses accumulate virus-derived
siRNAs in both plus and minus polarities, suggesting a role
for dsRNA in the initiation of antiviral RNAi. Furthermore,
diverse viral proteins essential for plant infection have been
identiﬁed as suppressors of RNAi [15].
In contrast to the widespread recognition of a natural anti-
viral role for RNA silencing in higher plants, no experimental
evidence was available until recently on whether or not RNA
silencing plays a similar antiviral role in the animal kingdom.
Here, we review recent progress in establishing RNA silencing
as a novel nucleic acid-based antiviral immunity in inverte-
brates and discuss features and possible functions of miRNAs
and RNAi suppressors encoded diverse mammalian viruses.2. Insect viruses induce and suppress antiviral silencing
Following the 1998 demonstration of dsRNA-mediated
RNAi in Caenorhabditis elegans [16], many arthropod species
have been found to support RNAi. These include fruit ﬂy
[17], medﬂy [18], milkweed bug [19], mosquito [20,21], giant
silkmoth [22], red ﬂour beetle [23], Noctuid moth [24], tick
[25], honeybee [26], and spider [27]. However, the ﬁrst direct
evidence establishing a natural antiviral role for RNAi in an
animal species was not reported until 2002 [28]. The experi-
mental system was based on infection of cultured D. melano-
gaster S2 cells with ﬂock house virus (FHV), a member of
the Nodaviridae family.
Nodaviruses contain a bipartite plus-strand RNA genome,
and are pathogens of insects and ﬁshes although one member,blished by Elsevier B.V. All rights reserved.
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mammals [29]. RNA1, the 1st genome segment of nodaviruses,
encodes the entire viral contribution to the viral RNA-depen-
dent RNA polymerase (RdRP) and replicates autonomously in
the absence of RNA2, which depends on RNA1 for replica-
tion. RNA2 directs the expression of the pre-capsid protein
(pre-CP) essential for virion packaging. Induction of antiviral
silencing in Drosophila cells upon FHV infection is supported
by several lines of evidence. First, FHV infection initiated by
FHV virions results in the rapid accumulation of the virus-spe-
ciﬁc 22-nt RNAs in infected cells, which were detected by both
RNA blot hybridization [28] and direct small RNA cloning
(H.W. Li and S.W. Ding, unpublished data). These small
RNAs correspond to both plus and negative strand FHV
RNAs, suggesting recognition and dicing of double-stranded
replicative intermediates into viral siRNAs by the Drosophila
RNAi machinery.
Second, increased accumulation of FHV RNAs was ob-
served in the ﬂy cells after the RNAi pathway was made par-
tially defective by depleting Ago2, a core component of the
siRNA-loaded RISC [9]. Thus, a functional RNA silencing
pathway naturally restricts FHV accumulation in infected fruit
ﬂy cells. Third, the B2 protein of FHV was identiﬁed as a sup-
pressor of antiviral silencing. B2 is encoded at the 3 0-end of
FHV RNA1, but unlike the viral RdRP that is translated di-
rectly from RNA1, B2 is translated from RNA3, a subgenomic
RNA transcribed during RNA1 replication. The silencing sup-
pressor activity of B2 was ﬁrst revealed using an RNA silenc-
ing assay established in transgenic plants [28]. Further work
showed that an FHV RNA1 mutant that does not express
B2 failed to accumulate to detectable levels in wild type Dro-
sophila cells, but the same mutant accumulated to wild type
levels in S2 cells defective for RNAi due to Ago2 depletion.
Thus, the essential role of B2 in FHV infection is suppression
of the Ago2-dependent antiviral silencing induced by FHV
replication in Drosophila cells [28].
Recent work showed that NoV RNA replication also trig-
gers the RNAi-mediated antiviral response in D. melanogaster
cells [30]. Abundant accumulation of NoV RNAs in cultured
Drosophila cells is dependent on either Ago2 depletion or
expression of B2 of either NoV or FHV. Although B2 of
NoV shares limited sequence similarity with FHV B2 (identity
<19%), it also suppresses RNA silencing in plants and rescues
the infection of the B2-deletion mutant of FHV in fruit ﬂy cells
[30]. Therefore, induction and suppression of RNAi-mediated
antiviral silencing in Drosophila cells is a conserved feature of
two distantly related nodaviruses, implicating RNAi as an
antiviral immunity in fruit ﬂies [13].
Comparative genomic analysis has revealed a conserved
RNAi pathway between D. melanogaster and the malaria mos-
quito Anopheles gambiae [31,32]. As observed in D. melanogas-
ter, NoV RNA replication in cultured An. gambiae cells also
triggers RNAi-mediated antiviral silencing [30]. B2 expression
is essential for the accumulation of NoV RNAs in transfected
cells but it became dispensable in An. gambiae cells depleted of
the mosquito Ago2 by RNAi. Thus, the RNAi machinery of
malaria mosquitoes has the capacity to detect the replicating
virus RNA and to mount an eﬀective antiviral response.
gypsy is an endogenous retrovirus of D. melanogaster. Pelis-
son and colleagues [33] show that sensor reporter constructs
carrying part of the gypsy sequence are silenced in ﬂy ovaries
in a manner dependent on the piwi argonaute gene. Notably,ﬂy ovaries accumulate gypsy-speciﬁc small RNAs of 25–
27 nt, indicating that the endogenous retrovirus is also targeted
for silencing in D. melanogaster by an RNAi mechanism [33].
We found recently that infection of D. melanogaster cells with
Cricket paralysis virus (CrPV) leads to accumulation of CrPV-
speciﬁc siRNAs and that CrPV encodes the activity to sup-
press the antiviral silencing response in D. melanogaster cells
(R. Aliyari and S.W. Ding, unpublished data). CrPV is an in-
sect RNA virus that is distinct to nodaviruses, but is closely re-
lated to animal picornaviruses [34]. Taken together, available
data show that RNAi represents a common antiviral response
in invertebrates and that eﬀective suppression of RNAi immu-
nity may be a key feature of invertebrate viruses.3. Do arboviruses induce and suppress antiviral silencing in
arthropod vectors?
Arthropod-borne viruses (arboviruses) include many danger-
ous human pathogens and most have an RNA genome such as
dengue viruses (DENV) and alphaviruses. However, arbovi-
ruses are not considered true insect viruses because they are typ-
ically not pathogenic to their insect hosts [35]. Early studies to
engineer pathogen-derived resistance against DENV have sug-
gested active antiviral silencing in Aedes aegypti [36,37]. Cul-
tured Ae. aegypti cells or female adults became resistant to
DENV after transfection with recombinant Sindbis alphavirus
(SINV) expressing a structural protein of DENV. Resistance
to DENV is serotype-speciﬁc and independent of the expression
of the DENV protein, indicating that it is RNA-mediated [36].
Insertion of part of an endogenous gene into the SINV vector
also leads to silencing of the corresponding gene in infectedmos-
quitoes. All of these features are reminiscent of the speciﬁcRNA
silencing of host endogenous genes and transgenes induced by
plant virus expression vectors [38,39].
Onyong-nyong virus (ONNV) is a human pathogenic alpha-
virus vectored by An. gambiae. Olson and colleagues showed
that co-injection of ONNV with dsRNA targeting An. gambiae
Ago2 resulted in higher virus titer and wider virus distribution
in adult female mosquitoes in comparison with co-injection of
a non-speciﬁc dsRNA [40]. Since the role of An. gambiae Ago2
to mediate antiviral RNAi is known [30], this ﬁnding suggests
an antiviral role for RNAi against an arbovirus in its arthro-
pod vector [40]. Demonstration of the accumulation of
ONNV-speciﬁc siRNAs in infected An. gambiae will further
support this conclusion.
As in mosquitoes, insertion of host genes into SINV resulted
in speciﬁc host gene silencing in the commercially used silk-
moth Bombyx mori infected with the recombinant virus [41].
Similar virus-induced gene silencing was also recently docu-
mented in cultured tick (Ixodes scapularis) cells infected with
a gene expression vector based on another alphavirus, Semliki
forest virus (SFV) [42]. Notably, the accumulation of alphavi-
rus-speciﬁc small RNAs was detected in insect cells infected
with either alphavirus, indicating that alphaviral RNA replica-
tion induces antiviral RNAi in these insects. However, it has
not been addressed in any of these systems whether or not
the accumulation of the alphavirus is downregulated by induc-
tion of the insect RNAi.
It remains unknown what is the molecular basis for the dif-
ference between arboviruses and insect viruses since both are
recognized by the RNAi machinery of insects. Our recent work
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pressor of antiviral silencing since none of the mature dengue
viral proteins is able to rescue the infection of the B2-deletion
mutant of FHV in fruit ﬂy cells (W.X. Li and S.W. Ding,
unpublished data). Thus, one attractive hypothesis is that un-
like true insect viruses, arboviruses do not encode a suppressor
of antiviral silencing. Alternatively, arbovirus-encoded RNAi
suppressors are not active or less active in insect hosts than
in their vertebrate hosts. As a result, replication and infection
of arboviruses may be restricted to insect tissues where antivi-
ral silencing is weak.4. RNAi-mediated antiviral silencing in C. elegans
The RNAi machinery of the nematode C. elegans contains
features of RNA silencing found unique in both vertebrates
and plants [6]. As found in mammals, C. elegans contains a sin-
gle Dicer that processes precursors of both miRNA and siR-
NA. However, C. elegans also supports transitive RNAi and
systemic RNAi, which are active in plants but apparently
not in mammals or D. melanogaster [12]. Until recently
[43,44], no experimental evidence was available on whether
or not the worm RNAi pathway is able to recognize and
mount an eﬀective defense against virus infection, although
dsRNA-mediated RNAi was ﬁrst demonstrated in C. elegans
[16]. This is at least partly because C. elegans is not known
to support replication of any virus.
Recently, Wilkins and colleagues [44] showed that Vesicular
stomatitis virus (VSV), which has a non-segmented, negative-
strand RNA genome, is able to infect primary cell cultures
of C. elegans. VSV accumulation is enhanced in cell cultures
derived from RNAi-defective worm mutants, but is inhibited
in cell cultures from mutants with an enhanced RNAi re-
sponse. Lu and colleagues [43] have shown complete replica-
tion of FHV in worms after transcriptional induction of
chromosomally integrated transgenes coding for full-length
cDNA copies of FHV genomic RNAs. Further analysis
showed that FHV replication in C. elegans triggers potent anti-
viral silencing that must be suppressed by FHV B2. A B2-deﬁ-
cient mutant of FHV, which does not accumulate in wild-type
animals, is eﬃciently rescued in a mutant carrying a loss-of-
function mutation in rde-1, which encodes a worm AGO essen-
tial for RNAi mediated by siRNAs but not by miRNA [6,45].
This genetic complementation of loss-of-function mutations in
a viral RNAi suppressor gene and a host RNAi pathway gene
provides the ﬁrst direct evidence in any host systems for a
counter-defense role of a virus-encoded RNAi suppressor.
This complementation has not been demonstrated in plants de-
spite the facts that plant viruses carrying loss-of-function
mutations in their suppressor gene exhibit defects in plant
infections and that plant viral suppressors target various steps
in the RNA silencing pathway [15].
B2 expression was also found to enhance virus accumulation
in the rde-1 mutant, indicating the presence of active antiviral
silencing in the C. elegans mutant that is possibly mediated by
an RDE-1 homolog. Notably, the C. elegans genome encodes
27 AGOs in total, among which diﬀerential requirements for
the Agos Alg-1, Alg-2, PPW-1 and PPW-2 in various RNAi
processes have been documented [46]. The number of AGO
genes in C. elegans is signiﬁcantly higher than the 5 found in
Drosophila and 10 in Arabidopsis [47], suggesting an evolution-ary strategy of host adaptation to viruses through expansion of
the AGO family. Although tobraviruses and nepoviruses use
plant-parasitic nematodes as their transmission vector [48],
there are no known natural viral pathogens of C. elegans.5. Mammalian virus-encoded miRNAs
The RNAi machinery of invertebrates and vertebrates shares
many features and neither may contain the RdRP component
found in fungi, plants and C. elegans. It has been controversial
whether or not RNAi acts as an antiviral immunity in verte-
brates as has been established in plants and invertebrates. In
2004, Tuschl and colleagues [49] reported the cloning and
detection of ﬁve virus-speciﬁc small RNAs of 21–23 nucleo-
tides from Burkitts lymphoma cell line latently infected with
Epstein-Barr virus (EBV), a human gammaherpesvirus. These
RNAs are considered miRNAs, not siRNAs, because of the
detection of both the fold-back structures ﬂanking the cloned
RNAs in the genomic sequence and the approximately 60-nt
precursor miRNAs (pre-miRNAs) in the infected cells. Fur-
thermore, EBV-infected cells accumulate an EBV-speciﬁc miR-
NA\, which corresponds to the opposite strand of an miRNA
in the predicted fold-back structure [49]. Thus far, a total of 34
miRNAs (plus 7 corresponding miRNA\s), all of which are en-
coded by human herpesviruses, have been cloned and veriﬁed
by northern blot analysis [49–52]. These include 11 miRNAs
from Kaposis sarcoma-associated gammaherpesvirus (KSHV)
and 9 miRNAs each from mouse gammaherpesvirus 68
(MGHV) and human cytomegalovirus (HCMV), a betaherpes-
virus. In addition, viral miRNAs have also been identiﬁed
from cells infected with Simian virus 40 (SV40) and adenovirus
by RNase protection assays and/or northern blot hybridiza-
tions [53,54].
These viral miRNAs can be as abundant as cellular miRNAs
as indicated by the frequency of cloning and northern blot
analysis. Like cellular miRNAs, most of the viral miRNAs
are likely to be processed from DNA-dependent RNA poly-
merase II (Pol II) transcripts and editing of the viral pre-miR-
NAs can occur [52]. However, all of the 9 MGHV miRNAs are
predicted to be transcribed by Pol III [52]. All of the viral miR-
NAs identiﬁed so far are encoded by DNA viruses of which
both DNA replication and mRNA transcription occur in the
nucleus. It will be of interest to determine if miRNAs are pro-
duced by poxviruses that contain large DNA genomes but rep-
licate extirely in the cytoplasm. RNA transcripts from these
cytoplasmic viruses would not have access to the nuclear
protein Drosha, which is required for the production of pre-
miRNA.
Production and detection of virus-speciﬁc small RNAs
demonstrate that the single mammalian Dicer is capable of
sensing the dsRNA feature of viral RNAs in infected cells
as found in C. elegans, which also encodes a single Dicer
[43]. Two classes of viral miRNAs have the antiviral poten-
tial in targeting important virus genes. First, four of the
cloned herpesviral miRNAs are perfectly complementary to
viral mRNAs transcribed in the opposite orientation
[49,53]. Since it is known that miRNAs can act like siRNAs
to cleave their target mRNAs [55,56], these viral miRNAs
may have an antiviral role to direct cleavages of their target
viral mRNAs. Indeed, Ganem and colleagues showed that
5968 H.-W. Li, S.-W. Ding / FEBS Letters 579 (2005) 5965–5973both the miRNA and its miRNA\ of SV40 mediate in vivo
cleavages of the perfectly complementary SV40 early tran-
scripts, which encode the viral T antigens [53]. Intriguingly,
down-regulation of T antigens by SV40 miRNAs had no ef-
fect on the production of infectious virus particles in cell
cultures. Instead, wild-type SV40-infected cells became less
sensitive to lysis by cytotoxic T cells than a mutant lacking
miRNAs. Thus, miRNA production is considered beneﬁcial
for SV40 under the conditions examined as the viruses main-
tain replicative eﬃciency by reducing excess antigen produc-
tion [53]. It will be important to determine if this is
reproduced in an animal model. Second, ﬁve known viral
miRNAs are located in the mature mRNA of viral pro-
tein-coding genes [49,52]. These include three 3 EBV miR-
NAs found within the 5 0 and 3 0 untranslated region of the
EBV protein-coding gene BHRF1, HCMV-miR-U112-1 in
the viral gene UL114, and KSHV-miR-10 in the kaposin
mRNA transcripts. Thus, excision of pre-miRNA from these
transcripts would also disrupt expression of the viral protein,
which may occur at the latent stage [49].
For most of the known viral miRNAs, however, bioinfor-
matics searches detected no highly complementary sites within
the coding regions of the corresponding viral genomes [49–52].
Thus, a popular hypothesis is that viral miRNAs act like true
miRNAs to down regulate expression of cellular and/or viral
genes by inhibiting their translation, which may play a critical
role in speciﬁc aspects of virus biology such as the establish-
ment and/or maintenance of herpesvirus latency [49,50]. How-
ever, the 34 miRNAs identiﬁed from the three closely related
gammaherpesviruses and one betaherpesvirus share no sub-
stantial sequence homology with one another [52]. Thus, it is
diﬃcult to reconcile how conserved host genes/functions are
targeted by such diverse viral miRNAs.
In addition to translational inhibition and cleavage of target
mRNAs, Arabidopsis miRNAs also guide chromatin modiﬁ-
cation by inducing DNA methylation downstream of the miR-
NA complementary sites [57,58]. In this regard, miRNAs can
be functionally equivalent to the centromeric siRNAs found
in ﬁssion yeast that act as speciﬁcity factors to initiate hetero-
chromatin assembly [59]. The role of siRNAs in directing
repressive chromatin and/or DNA modiﬁcations appears to
be conserved in plants, Drosophila and mammals [60,61]. Fur-
thermore, it is known that the genomic DNA of nucleus-repli-
cating viruses is assembled into mini-chromatin with host
histones and other chromatin proteins and that DNA methyl-
ation targets and represses genome expression of human DNA
viruses [62]. Thus, an entirely untested but intriguing possibil-
ity is that viral miRNAs may induce in cis viral DNA methyl-
ation and/or methylation of cellular histones associated with
the viral DNA in the nucleus, in a manner similar to hetero-
chromatin siRNAs.
It is interesting to note that viral miRNAs cloned from
cells latently infected with three herpesviruses are clustered
in latency-associated regions, whereas HCMV miRNAs
cloned from lytically infected cells are spread across the viral
genome [50–52]. It is possible that the highly clustered, la-
tency-associated viral miRNAs play a role in the initiation
and/or maintenance of the latent state of herpesviral infec-
tion in a position-dependent manner. This model can be eas-
ily tested by determining if the mammalian RNAi machinery
and/or viral suppressors of RNAi play any role in virus
latency.6. Mammalian antiviral immunity directed by cellular miRNAs
A recent study from the Voinnet lab discovered a novel type
of mammalian antiviral immunity mediated by a cellular miR-
NA [63]. A miR-32 complementary site was identiﬁed and
mapped to the 3 0 UTR shared by ﬁve mRNAs of the retrovirus
primate foamy virus type 1 (PFV-1). A PFV-1 mutant carrying
mutations that disrupt the partial complementation with miR-
32 accumulated to much higher levels than the unmodiﬁed
virus in infected cells. A defensive role for the RNAi pathway
in mammalian cells against PFV-1 is further supported by the
observation that the Tas protein encoded by PFV-1 suppresses
RNA silencing mediated by either miRNAs or siRNAs [63].
Several important predictions can be made based on this dis-
covery. First, the large numbers of miRNAs identiﬁed for each
animal species (e.g., >500 in human) and the broad spectrum
of genes targeted by each miRNA (up to 200 human genes/
miRNA) [64,65] predict that many cellular miRNAs may have
antiviral potential. Second, it is likely that the expression pat-
tern of cellular miRNAs may play a role in the pathogenesis,
tissue tropism, and/or host range of individual viruses. Third,
the combined speciﬁcity repertoire of host miRNAs may inﬂu-
ence the rate and direction of virus evolution. This could be
particularly signiﬁcant for viruses with an RNA genome be-
cause of high error rates in RNA replication. It has been doc-
umented that both human immunodeﬁciency virus (HIV) and
poliovirus readily escape highly eﬀective, artiﬁcially introduced
siRNAs through unique point mutations within the targeted
regions [66–69].7. Mammalian viral suppressors of RNAi
The ﬁrst indication for an antiviral potential of the mamma-
lian RNAi pathway came from the identiﬁcation of RNAi sup-
pressors encoded by mammalian viruses [28,30]. RNAi
suppression by B2 of FHV and NoV, vaccinia E3L, and NS1
of human inﬂuenza A, B, and C viruses were ﬁrst demonstrated
in insect cells [30] and their activities in suppressing RNAi med-
iated by siRNAs andmiRNAs were later conﬁrmed in mamma-
lian cells ([70]; Li H.W. and Ding S.W., unpublished data). In
addition, VA1 of adenovirus [54,71], NSs of La Crosse virus
[72], r3 of reovirus [73], Tat of HIV [74], and Tas of PFV-1
[63] also exhibit RNAi suppressor activity in mammalian cells.
VA1 is a highly structured RNA of about 160 nt transcribed
from a viral Pol III promoter during viral infection. Notably,
these RNAi suppressors are encoded by genetically diverse
viruses whose genome types include dsDNA (vaccinia and ade-
novirus), dsRNA (reovirus), segmented plus-strand (nodavi-
ruses) and negative-strand (inﬂuenza and La Crosse viruses)
RNA, and plus-strand RNA replicated via DNA intermediates
(HIV and PFV-1 retroviruses). Many mammalian viruses are
sensitive to inhibition of RNAimediated by introduced siRNAs
[75], which, however, does not necessarily argue against the pos-
sibility that they may encode a RNAi suppressor. Engineered
virus resistance based on RNAi is also eﬀective against a wide
range of plant viruses carrying diverse RNAi suppressors [76].
This is probably because viral suppression of RNAi is always
partial or is eﬀective against only one of the antiviral silencing
pathways [77]. Thus, the evolutionarily ﬁne tuned viral coun-
ter-defensemaybecome ineﬀective uponup-regulationof antivi-
ral silencing by artiﬁcial means.
H.-W. Li, S.-W. Ding / FEBS Letters 579 (2005) 5965–5973 59697.1. RNAi suppression assays
Two types of assays have been used to identify mammalian
viral suppressors of RNA silencing according to whether or
not the silencing inducer is a replicating virus. Replication of
the RNA1 mutant of either FHV or NoV expressing no B2
does not lead to a readily detectable accumulation in cultured
Drosophila S2 cells because of antiviral silencing in a RISC-
dependent manner [28,30]. Rescue of either RNA1 mutant as
determined by Northern blot detection of virus RNAs occurs
when S2 cells are co-transfected with a plasmid directing
expression of an RNAi suppressor. The readout of this silenc-
ing suppression assay can also be expression of green ﬂuores-
cent protein (GFP) after the GFP coding sequence is fused
in frame with the initiation codon of B2 in RNA1 of either
FHV or NoV [30]. A similar assay that is based on suppression
of the RISC-dependent silencing of the replicating NoV RNA1
has been developed in cultured mosquito cells using a constitu-
tive promoter to drive the in vivo transcription of the viral
RNA1 [30].
B2 of NoV also enhances the accumulation of both RNA1
and the RNA1-derived RNA3 of NoV in HeLa cells [78]
and B2 of both NoV and FHV can inhibit RNAi triggered
artiﬁcially in human cells ([70]; Li H.W. and Ding S.W.,
unpublished data). However, it is not known if the enhanced
NoV accumulation in HeLa cells is due to a RISC-depen-
dent RNAi triggered by NoV RNA replication. Therefore,
suppression of antiviral silencing by many of the known
mammalian viral suppressors such as B2, NS1, and E3L
were ﬁrst shown in heterologous systems established either
in insect cells or in plants [28,30]. For that reason, demon-
stration of the RNAi suppression activity in mammalian
cells relies on induction of RNAi mediated by synthetic siR-
NAs, short hairpin RNAs (shRNAs) transcribed from trans-
gene constructs, or cellular miRNA.
The most commonly used inducer of RNAi in mammalian
cells is the chemically synthesized siRNAs of 21-nt that are
5 0-phosphorylated and contain 2-nt overhangs at the 3 0-ends
[79]. However, identiﬁcation of many viral RNAi suppressors
in mammalian cells involves the use of shRNAs
[54,70,71,74]. shRNAs is analogous to pre-miRNAs because
it requires de novo processing into siRNAs followed by RISC
assembly. Thus, use of shRNAs as RNAi triggers will identify
suppressors that target those early steps. Indeed, several
known suppressors are inactive when synthetic siRNAs were
used to induce RNAi (see below). In addition, perfectly and
imperfectly complementary sites for cellular miRNAs cloned
into the 3 0-UTR of reporter constructs can sense RNA cleav-
age and translational inhibition respectively mediated by the
cognate miRNAs. This type of sensor constructs has been suc-
cessfully used to identify the RNAi suppressor activity of Tas
in mammalian cells [63].
Both endogenous genes and transgenes encoding GFP or
luciferase have been used as the reporter target gene in RNAi
suppression assays. An eGFP-based reporter constructed re-
cently was shown particularly useful for this purpose [70].
The plasmid encodes an engineered PEST sequence that desta-
bilizes eGFP to allow real time correlation between ﬂuores-
cence and mRNA levels of GFP [80]. In addition, six extra
copies of the shRNA target site were inserted into the 3 0-
UTR to enhance sensitivity to RNAi [70].
Inducible silencing of a reporter GFP transgene integrated in
the genome of Nicotiana benthamiana plants was used in theidentiﬁcation of the ﬁrst animal viral suppressor of RNAi
[28,81]. Among the known mammalian viral suppressors,
E3L, Tat, NSs and VA have not been assayed in plant systems;
however, B2 [30], NS1 [82,83], and Tas [63] are all active sup-
pressors of plant RNA silencing. r3 of reovirus also suppresses
RNA silencing in plants although this activity has yet to be
conﬁrmed in animal cells [73]. This is important as it appears
that over expression of any dsRNA-binding protein including
an Escherichia coli protein results in suppression of transgene
silencing in this plant assay [73]. In contrast, antiviral silencing
induced by the replicating FHV RNA in Drosophila cells is
insensitive to over expression of many cellular dsRNA-binding
proteins [30].7.2. RNAi suppression mechanisms
Most of the mammalian viral suppressors reported to date
are dsRNA-binding proteins. E3L and r3 contain a canon-
ical dsRNA-binding domain (dsRBD). However, the struc-
tural motif of NS1 involved in dsRNA binding forms a
symmetric homodimer with a six-helix chain fold [84,85] that
is distinct from either the canonical dsRBD or p19 [86,87].
Similarly, both B2 and Tat share no homology at the pri-
mary sequence level with any of the known dsRNA-binding
proteins. Tat binds to perfect base-paired dsRNA as well as
a 59-nt stem–loop structure called trans-activation (TAR) re-
sponse element of HIV RNA [88]. Both NS1 [30,83] and B2
[43,70] bind siRNAs in addition to long dsRNA, but siRNA
binding has not been tested for any of the other suppressors
and it is also unknown if Tas or NSs binds long dsRNAs.
Interestingly, B2 also binds to the imperfectly base-paired
human pre-miRNAs [70] and exhibits a 30-fold higher aﬃn-
ity to long dsRNA than siRNAs [43]. A single amino acid
replacement at position 54 of FHV B2 (R54Q) largely elim-
inated its activity to suppress antiviral silencing and to bind
long dsRNA but it did not completely abolished siRNA-
binding [43]. Thus, B2 may inhibit antiviral silencing by tar-
geting the precursor of siRNAs [43], in contrast to p19 of
the plant tombusvirus, which has much weaker aﬃnity to
siRNA duplexes longer than 23 nt and inhibits the assembly
of siRNAs into RISC [86,87,89]. dsRNA as a cellular target
of B2 perhaps explains why B2 can suppress RNAi in a
wide range of host species including plants, fruit ﬂies, mos-
quitoes, worms and mammals [28,30,43,70].
Although B2 inhibits RNAi induced by either shRNA or
siRNA in mammalian cells, shRNA-induced RNAi is sev-
eral-fold more sensitive to B2 [70]. Moreover, both Tat and
VA1 suppress RNAi induced by shRNAs but not siRNA-in-
duced RNAi [71,74]. Accumulation of VA1 appears to inhibit
both the processing and export of shRNA transcripts and pre-
miRNA in mammalian cells [54,71]. Over expression of B2 in
human cells also increase the accumulation of shRNA tran-
scripts and at least one endogenous pre-miRNA examined
[70]. These data suggest that B2, Tat, and VA1 may act up-
stream of Dicer cleavage. Indeed, all three suppressors inhibit
the in vitro cleavage of dsRNA by human Dicer [70,71,74] and
FHV B2 also blocks siRNA production from dsRNA by Dro-
sophila Dicer extracts [43].
Available data further indicate that these suppressors may
target the dicing step by distinct mechanisms. VA1 RNA binds
Dicer in vitro [54,71] and serves as a substrate of Dicer in vitro
and in vivo, leading to production of VA-speciﬁc miRNAs
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tering Dicer. In contrast, B2 inhibition of siRNA production
by Drosophila Dicer extracts is correlated with its ability to
bind long dsRNA because the inhibitory eﬀect of B2 was
essentially eliminated by the R54Q mutation [43]. Thus, B2
may inhibit RNAi by mainly preventing the processing of
the siRNA precursor, which is distinct to that proposed for
p19 via sequestering siRNAs [89].
Tat inhibition of the Dicer activity may be distinct from its
activity in either RNA binding or transcriptional activation, as
suggested by the contrasting activities of two Tat mutants [74].
Replacement of Lys by Ala at position 51 (K51A) abolished
the RNAi suppression activity of Tat without any eﬀect on
its transcriptional activity whereas the opposite was true when
the same replacement was made at position 41 of Tat (K41A).
Notably, the transcriptionally active, RNAi suppression-deﬁ-
cient TatK51A is fully active for RNA binding [74]. However,
it remains to be determined if Tat or TatK51A binds siRNAs.7.3. Functional roles of RNAi suppression in virus infection
Introduction of the TatK51A mutation into HIV led to a
modest decrease in the accumulation of the recombinant
HIV in infected human cells in comparison with the wild type
[74]. Similarly, an NoV mutant that does not express B2 exhib-
its a defect in virus accumulation as severe in some human cell
lines as in fruit ﬂy and mosquito cell lines [30,78]. In fact, all of
the virus-encoded RNAi suppressors identiﬁed to date are re-
quired for virus infection in mammalian cells. However, most
of these suppressors, including NS1, E3L, Tat, and VA1, are
also known to function in their mammalian hosts as inhibitors
of the innate antiviral immunity regulated by the interferon
system [90]. In particular, inhibition of the IFN/PKR-medi-
ated immunity by NS1 and E3L [90] requires the dsRNA bind-
ing motif implicated in RNAi suppression [30,43]. Thus, it will
be critical to establish if the requirement of these RNAi sup-
pressors in the infection of mammalian hosts is due to a spe-
ciﬁc RNAi suppression and independent of or in addition to,
their active suppression of IFN/PKR-mediated immunity. In
this regard, it may be particularly informative to know if Tat-
K51A, deﬁcient in RNAi suppression but active in RNA bind-
ing [74], remains active in the suppression of the IFN response.
This issue has been resolved in invertebrates, which do not
contain the IFN/PKR system, because virus mutants carrying
loss-of-function mutations in the RNAi suppressor gene are
speciﬁcally rescued in cell cultures [28,30,44] and whole organ-
isms [43] either by RNAi depletion of Ago2 or by a genetic
loss-of-function mutation in an RNAi pathway gene. Use of
similar genetic knock-out mouse cell lines [91] or knocking-
down expression of RNAi pathway genes by siRNAs should
help clarify this controversial issue in mammalian systems. A
complementary approach is to determine if expression of
mammalian RNAi suppressors enhances virus accumulation
in mammalian cell lines (e.g., Vero cells) or animal models deﬁ-
cient in IFN/PKR-mediated immunity.
Identiﬁcation of viral suppressors eﬀective against RNAi
induced by shRNAs but not siRNAs may have provided a
clue for their biological function as viral regulators of the
miRNA pathway. Indeed, Tas, VA1, B2 and NS1 also sup-
press RNAi mediated by miRNAs ([63,71] Li H.W. and
Ding S.W., unpublished data). Thus, viral RNAi suppressors
may play a counter-defensive role in modulating the target-ing of viral genes or host genes by either cellular and/or vir-
al miRNAs. Interference of miRNA-regulated expression of
host genes may also provide a new mechanism of mamma-
lian viral pathogenesis as has been proposed for plant viral
RNAi suppressors [92,93]. Notably, NS1 is localized in the
nucleus of infected cells and may thus have a potential to
disrupt the biogenesis of mammalian miRNAs and the
RNAi-directed assembly of heterochromatin in the nucleus.8. Conclusions and perspectives
Available data clearly support a naturally antiviral role for
RNAi in invertebrate animals. As has been demonstrated for
plant viruses, invertebrate viruses induce RNAi that speciﬁ-
cally targets the infecting virus RNAs and they encode RNAi
suppressors that are essential for virus infection. Moreover, the
rescue of nodaviral mutants deﬁcient in RNAi suppression in
insect cells and worms deﬁcient in RNAi provides direct evi-
dence for a speciﬁc requirement of viral suppression of the
RNAi antiviral immunity during virus infection. This type of
genetic complementation has not been demonstrated for any
of the several dozens of plant viral suppressors. It is evident
that RNAi also protects arthropod vectors against arboviruses
because of the detection of viral siRNAs and homology-depen-
dent silencing of RNA molecules in infected insects. However,
most of these observations have been made in cell cultures and
it is largely unknown if adult invertebrates will respond to
virus infection in a similar manner. It is possible that antiviral
silencing is mediated by the siRNA pathway because antiviral
silencing in D. melanogaster and C. elegans requires an Ago
member not essential for miRNA function. This predicts an
involvement of D. melanogaster Dicer-2 in the production of
viral siRNAs, which, however, remains to be conﬁrmed. Given
the availability of the fruit ﬂy and worm mutants carrying ge-
netic mutations in genes involved in well deﬁned steps of RNAi
pathways, it is likely that these host models will facilitate fur-
ther genetic and molecular dissection of the RNAi-mediated
antiviral silencing pathway in invertebrates.
Several lines of data suggest that miRNAs play a role in
mammalian responses to virus infection. These include the
demonstration of antiviral silencing directed by a cellular miR-
NA and the identiﬁcation of RNAi suppressors encoded by di-
verse mammalian viruses. In addition, production of viral
miRNAs demonstrates recognition of the nucleus-replicating
DNA viruses by the mammalian RNAi machinery. Moreover,
speciﬁc virus RNA silencing has been demonstrated for two
SV40 miRNAs and proposed for nine herpesviral miRNAs.
Much less is clear about the role of siRNAs in mammalian re-
sponses to viruses. dsRNA is produced during replication of
viruses with an RNA genome and of some DNA viruses due
to symmetrical transcription of both viral DNA strands [94].
Induction of antiviral silencing by two cytoplasmic replicating
RNA viruses recently demonstrated in a single Dicer organ-
ism, C. elegans, suggests an antiviral potential of the human
Dicer. However, large small RNA cloning projects had not
identiﬁed viral miRNAs or siRNAs from human cells infected
with Hepatitis C virus (HCV), yellow fever virus (YFV), or
HIV [52]. Two and four small RNAs were each cloned once
from HIV and YFV infected cells, respectively, but all are in
plus-sense orientation and from genomic regions not predicted
H.-W. Li, S.-W. Ding / FEBS Letters 579 (2005) 5965–5973 5971to form structures similar to pre-miRNAs. In addition, infec-
tion of HCV did not interfere with RNAi of a host mRNA
mediated by either siRNAs or shRNAs, suggesting that
infection of these plus-strand RNA viruses in cell cultures
may escape detection of the mammalian RNAi machinery so
that active viral suppression of RNAi is not required [52].
Nevertheless, the siRNA hypothesis has not been examined
rigorously for many mammalian viruses and use of RNAi-
deﬁcient cell lines coupled with ectopic expression of well-
deﬁned RNAi suppressors may prove informative.
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